(XNAS) Xtrackers NASDAQ 100 1C - Ratings and Ratios
Exchange-Traded Fund, US Large-Cap, Growth Equities
Description: XNAS Xtrackers NASDAQ 100 1C
The Xtrackers NASDAQ 100 UCITS ETF 1C (XETRA:XNAS) is a German-originated ETF that tracks the Morningstar US Large-Cap Growth Index, providing investors with exposure to the US large-cap growth equity market. The fund is designed to replicate the performance of the underlying index, which comprises stocks of prominent growth companies.
From a technical analysis perspective, the ETF is currently trading at €44.05, with a 20-day simple moving average (SMA) of €43.76, indicating a bullish trend. The 50-day SMA is at €42.04, and the 200-day SMA is at €43.82, further supporting the positive momentum. The average true range (ATR) is 0.59, equivalent to 1.33%, suggesting relatively moderate volatility. The ETF has reached a 52-week high of €49.08 and a low of €35.96, indicating a significant price range over the past year.
With assets under management (AUM) of €669.13 million, the Xtrackers NASDAQ 100 UCITS ETF 1C is a sizable fund, indicating a reasonable level of liquidity and investor interest. As the fund tracks the Morningstar US Large-Cap Growth Index, it is likely to be influenced by the overall performance of the US stock market, particularly in the technology and growth sectors, which have a significant weighting in the NASDAQ 100.
Based on the technical and fundamental data, a forecast for the XNAS ETF can be derived. Given the bullish trend indicated by the SMAs and the relatively moderate volatility, a potential price target for the ETF could be €46.50 in the short term, representing a 5.5% increase from the current price. However, this is contingent upon the overall market conditions and the performance of the underlying index. A potential risk to this forecast is a market downturn or a sector rotation away from growth stocks, which could negatively impact the ETFs price.
Additional Sources for XNAS ETF
XNAS ETF Overview
Market Cap in USD | 790m |
Category | US Large-Cap Growth Equity |
TER | 0.20% |
IPO / Inception | 2021-01-21 |
XNAS ETF Ratings
Growth Rating | 59.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -8.5 |
Analysts | - |
Fair Price Momentum | 40.92 EUR |
Fair Price DCF | - |
XNAS Dividends
Currently no dividends paidXNAS Growth Ratios
Growth Correlation 3m | 84.6% |
Growth Correlation 12m | 24.3% |
Growth Correlation 5y | 81.2% |
CAGR 5y | 13.80% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | 0.17 |
Alpha | -11.92 |
Beta | 1.018 |
Volatility | 14.82% |
Current Volume | 29.2k |
Average Volume 20d | 33.1k |
As of July 03, 2025, the stock is trading at EUR 44.39 with a total of 29,159 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +2.91%, over three months by +6.91% and over the past year by +4.08%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers NASDAQ 100 1C (XETRA:XNAS) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.64 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XNAS is around 40.92 EUR . This means that XNAS is currently overvalued and has a potential downside of -7.82%.
Xtrackers NASDAQ 100 1C has no consensus analysts rating.
According to our own proprietary Forecast Model, XNAS Xtrackers NASDAQ 100 1C will be worth about 48.1 in July 2026. The stock is currently trading at 44.39. This means that the stock has a potential upside of +8.25%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 48.1 | 8.2% |